Source: Eur Respir J, 51 (5) 1800755; 10.1183/13993003.00755-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Clémence Martin, Lucile Regard, Pierre-Régis Burgel. Cured bronchi! Extending the use of nebulised hypertonic saline outside of cystic fibrosis?. Eur Respir J, 51 (5) 1800755; 10.1183/13993003.00755-2018

Member's Comments

No comment yet.

Related content which might interest you: RCT Abstract - The effect of inhaled hypertonic saline on lung structure in preschool children with cystic fibrosis Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Effects of dornase alfa and hypertonic saline on gas mixing in lung periphery in children with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 The efficacy and tolerability of inhaled hypertonic saline in children with cystic fibrosis Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis Year: 2020 Intervention trials and ventilation distribution in mild cystic fibrosis lung disease: will it all come out in the wash? Source: Eur Respir J 2011; 37: 757-759 Year: 2011 Effect of short-term inhalation of warm saline atomised gas on patients with non-cystic fibrosis bronchiectasis Source: ERJ Open Res, 6 (1) 00130-2019; 10.1183/23120541.00130-2019 Year: 2020 Effects of hypertonic saline on sputum clearance in patients with bronchiectasis Source: International Congress 2016 – Best abstracts on innovative outcomes and novel interventions in respiratory physiotherapy Year: 2016 Nebulised 7% hypertonic saline improves health related quality of life in patients with non-cystic fibrosis bronchiectasis Source: Annual Congress 2011 - Chest physiotherapy and breathing retraining Year: 2011 Hypertonic saline nebulization combined with oscillatory positive expiratory pressure accelerate sputum clearance in cystic fibrosis: A randomised crossover trial Source: International Congress 2016 – Physiotherapy management of the ill but spontaneously-breathing adult patient Year: 2016 Nebulised 7 % hypertonic sodium chloride improves lung function and airway clearance in non cystic fibrosis bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Safety and efficacy of 7% hypertonic saline in patients with bronchiectasis Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 The in vitro effect of nebulised hypertonic saline on human bronchial epithelium Source: Eur Respir J, 51 (5) 1702652; 10.1183/13993003.02652-2017 Year: 2018 Effects of intrabronchial terlipressin versus cold normal saline solution application in endobronchial bleeding Source: Annual Congress 2007 - Therapeutic bronchoscopy Year: 2007 Audit of once daily nebulised hypertonic 6% saline (HTS) in adult bronchiectasis Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Inhaled antibiotics in cystic fibrosis: what we should do and what we still do not know Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016 The use of telehealth system in improving adherence to nebulised treatment in children with cystic fibrosis: Benefits and pitfalls Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014 Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics? Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections Year: 2016